Edoxaban Dosing Regimens Evaluated for AF-Related Stroke
The comprehensive net clinical outcomes of low- and high-dose edoxaban was evaluated for stroke in atrial fibrillation.
All articles by Jessica Nye, PhD
Inclisiran Safe, Effective in Reducing LDL-C in Patients With Familial Hypercholesterolemia or ASCVD
Researchers conducted a patient-level pooled analysis from phase 3 trials of inclisiran in patients with familial hypercholesterolemia or ASCVD.
Atrial Fibrillation Burden at 6 Months Better Predictor Than 30-Second Atrial Fibrillation Recurrence
The study authors analyzed the association of atrial fibrillation recurrence with heart failure, atrial fibrillation burden, and clinical outcomes in HF patients with AF.
BBV152: Inactivated COVID-19 Vaccine Enhances Immune Response, Phase 1 Results
The BBV152 vaccine, produced by Bharat Biotech International, was a whole-virion -propiolactone-inactivated SARS-CoV-2 vaccine formulated by Algel-alum or Algel-IMDG adjuvants.
Expansion of SARS-CoV-2 Surveillance Required for Epidemic Prevention
Study authors assessed the economic trade-offs of expanding and accelerating testing for SARS-CoV-2 across the United States in different transmission scenarios.
Potent Up-Front Antiplatelet Therapy Lowers Mortality for Patients With ACS
Researchers compared a potent antiplatelet inhibition strategy with a less potent inhibition treatment plan in patients with acute coronary syndrome undergoing coronary artery bypass surgery.
Ascorbic Acid and Zinc Gluconate Do Not Improve COVID-19 Symptoms
Study authors examined the effect of high-dose zinc and/or ascorbic acid on the severity or reduction of SARS-CoV-2 duration compared with the standard of care.
Short Periods of Intense Physical Activity Associated With Cardiorespiratory Fitness—Especially in Men With Type 2 Diabetes
Bouts of intense exercise can lead to cardiorespiratory fitness and decreased risk for cardiovascular disease in patients with type 2 diabetes.
High Efficacy of Pfizer COVID-19 Vaccine in a Nationwide Mass Vaccination Program
Study authors analyzed data from Israel’s largest health care organization to evaluate the effectiveness of Pfizer’s COVID-19 mRNA vaccine, BNT162b2, in a real world setting.
COVID-19 Testing: Saliva NAAT Comparable to Nasopharyngeal Swabs
Study authors assessed the diagnostic accuracy of saliva NAAT for COVID-19 due to the increased resources, such as trained personnel, required for nasopharyngeal swab NAAT.
-
Loading...
-
Loading...
Next post in General Cardiology
